PURPOSE: In breast MRI, skin and fibroglandular tissue commonly possess similar signal intensities, and as such, the inclusion of skin as dense tissue leads to an overestimation in the measured density. This study investigated the impact of skin to the quantitative measurement of breast density using MRI. METHODS: The analysis was performed on the normal breasts of 50 women using nonfat-saturated (nonfat-sat) T1 weighted MR images. The skin was segmented by using a dynamic searching algorithm, which was based on the change in signal intensities from the background air (dark), to the skin (moderate), and then to the fatty tissue (bright). Tissue with moderate intensities that fell between the two boundaries determined based on the intensity gradients (from air to skin, and from skin to fat) was categorized as skin. The percent breast density measured with and without skin exclusion was compared. Also the relationship between the skin volume and the breast volume was investigated. Then, this relationship was used to estimate the skin volume from the breast volume for skin correction. RESULTS: The percentage of the skin volume normalized to the breast volume ranged from 5.0% to 15.2% (median 8.6%, mean +/- STD 8.8 +/- 2.6%) among 50 women. The percent breast densities measured with skin (y) and without skin (x) were highly correlated, y = 1.23x+7% (r = 0.94, p < 0.001). The relationship between the skin volume and the breast volume was analyzed based on transformed data (the square root of the skin volume vs the cube root of breast volume) using the linear regression, and yielded r = 0.87, p < 0.001. When this model was used to estimate the skin volume for correction in the density analysis, it provided a better fit to the measured density with skin exclusion (with adjusted R2 = 0.98, and root mean square error = 1.6) compared to the correction done by using a fixed cutoff value of 8% (adjusted R2 = 0.83, root mean square error = 4.7). CONCLUSIONS: The authors have shown that the skin volume is related to the breast volume, and this relationship may be used to correct for the skin effect in the MRI-based density measurement. A reliable quantitative density analysis method will aid in clinical investigation to evaluate the role of breast density for cancer risk assessment or for prediction of the efficacy of risk-modifying drugs using hormonal therapy.
PURPOSE: In breast MRI, skin and fibroglandular tissue commonly possess similar signal intensities, and as such, the inclusion of skin as dense tissue leads to an overestimation in the measured density. This study investigated the impact of skin to the quantitative measurement of breast density using MRI. METHODS: The analysis was performed on the normal breasts of 50 women using nonfat-saturated (nonfat-sat) T1 weighted MR images. The skin was segmented by using a dynamic searching algorithm, which was based on the change in signal intensities from the background air (dark), to the skin (moderate), and then to the fatty tissue (bright). Tissue with moderate intensities that fell between the two boundaries determined based on the intensity gradients (from air to skin, and from skin to fat) was categorized as skin. The percent breast density measured with and without skin exclusion was compared. Also the relationship between the skin volume and the breast volume was investigated. Then, this relationship was used to estimate the skin volume from the breast volume for skin correction. RESULTS: The percentage of the skin volume normalized to the breast volume ranged from 5.0% to 15.2% (median 8.6%, mean +/- STD 8.8 +/- 2.6%) among 50 women. The percent breast densities measured with skin (y) and without skin (x) were highly correlated, y = 1.23x+7% (r = 0.94, p < 0.001). The relationship between the skin volume and the breast volume was analyzed based on transformed data (the square root of the skin volume vs the cube root of breast volume) using the linear regression, and yielded r = 0.87, p < 0.001. When this model was used to estimate the skin volume for correction in the density analysis, it provided a better fit to the measured density with skin exclusion (with adjusted R2 = 0.98, and root mean square error = 1.6) compared to the correction done by using a fixed cutoff value of 8% (adjusted R2 = 0.83, root mean square error = 4.7). CONCLUSIONS: The authors have shown that the skin volume is related to the breast volume, and this relationship may be used to correct for the skin effect in the MRI-based density measurement. A reliable quantitative density analysis method will aid in clinical investigation to evaluate the role of breast density for cancer risk assessment or for prediction of the efficacy of risk-modifying drugs using hormonal therapy.
Authors: Jun Wei; Heang-Ping Chan; Mark A Helvie; Marilyn A Roubidoux; Berkman Sahiner; Lubomir M Hadjiiski; Chuan Zhou; Sophie Paquerault; Thomas Chenevert; Mitchell M Goodsitt Journal: Med Phys Date: 2004-04 Impact factor: 4.071
Authors: Saskia van Engeland; Peter R Snoeren; Henkjan Huisman; Carla Boetes; Nico Karssemeijer Journal: IEEE Trans Med Imaging Date: 2006-03 Impact factor: 10.048
Authors: M J Yaffe; N F Boyd; J W Byng; R A Jong; E Fishell; G A Lockwood; L E Little; D L Tritchler Journal: Eur J Cancer Prev Date: 1998-02 Impact factor: 2.497
Authors: Michael Khazen; Ruth M L Warren; Caroline R M Boggis; Emilie C Bryant; Sadie Reed; Iqbal Warsi; Linda J Pointon; Gek E Kwan-Lim; Deborah Thompson; Ros Eeles; Doug Easton; D Gareth Evans; Martin O Leach Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-09 Impact factor: 4.254
Authors: Diane M Renz; Pascal A T Baltzer; Joachim Böttcher; Fady Thaher; Mieczyslaw Gajda; Oumar Camara; Ingo B Runnebaum; Werner A Kaiser Journal: Eur Radiol Date: 2008-06-04 Impact factor: 5.315
Authors: Norman F Boyd; Lisa J Martin; Johanna M Rommens; Andrew D Paterson; Salomon Minkin; Martin J Yaffe; Jennifer Stone; John L Hopper Journal: Methods Mol Biol Date: 2009
Authors: Norman Boyd; Lisa Martin; Anoma Gunasekara; Olga Melnichouk; Gord Maudsley; Chris Peressotti; Martin Yaffe; Salomon Minkin Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-06 Impact factor: 4.254
Authors: Daniel H-E Chang; Jeon-Hor Chen; Muqing Lin; Shadfar Bahri; Hon J Yu; Rita S Mehta; Ke Nie; David J B Hsiang; Orhan Nalcioglu; Min-Ying Su Journal: Med Phys Date: 2011-11 Impact factor: 4.071
Authors: Leah C Henze Bancroft; Roberta M Strigel; Erin B Macdonald; Colin Longhurst; Jacob Johnson; Diego Hernando; Scott B Reeder Journal: Magn Reson Med Date: 2021-11-14 Impact factor: 4.668
Authors: Lee-Jane W Lu; Thomas K Nishino; Raleigh F Johnson; Fatima Nayeem; Donald G Brunder; Hyunsu Ju; Morton H Leonard; James J Grady; Tuenchit Khamapirad Journal: Phys Med Biol Date: 2012-10-09 Impact factor: 3.609